Fladgate LLP has advised US based Flagship Food Group (Flagship Foods) on the acquisition of UK Atlantic Foods Group, Ltd (Atlantic Foods). The enlarged group supplies frozen, shelf-stable and fresh products into both retail and food service markets and also offers food packaging and logistic services and will have a combined turnover in excess of […]
As a sponsor of the 2013 Constructing Excellence in London and the South East Awards, Fladgate is delighted to congratulate the winners. The highly coveted awards were presented at a gala dinner on 20 June, attended by more than 300 leading construction industry professionals. Client of the Year University of Reading Integration & Collaborative Working […]
Fladgate LLP has, again, retained a top 20 ranking in the Corporate Advisers Rankings Guide AIM table. In the latest issue, the firm is in joint 15th position having moved up two places, acting for 21 AIM companies. Fladgate works with and acts for a number of AIM companies and their nominated advisers and brokers, […]
The “Business Premises Renovation Allowance” (BPRA) tax relief scheme, which was due to expire in 2012 but subsequently extended until 2017, remains a popular development incentive. Fladgate LLP has advised on four transactions in quick succession that are intended to benefit from the availability of this relief. The transactions included advising Maven Capital Llandudno LLP […]
Fladgate LLP has acted for AIM listed Tri-Star Resources Plc (Tri-Star) on a placing, raising gross proceeds of £500,000 at 0.3 pence per ordinary share. Tri-Star also entered into a non-binding letter of intent for the acquisition of Portage Minerals Inc for an all share consideration of approximately £3.5m. Tri-Star is an independent mining company […]
Fladgate LLP has advised Morria Biopharmaceuticals Plc (Morria) on the commencement of trading of Morria’s American Depositary Shares, representing its ordinary shares, on the OTC Bulletin Board in the United States. Morria is an emerging growth biopharmaceutical company focused on the development of first-in-class drugs, multi-functional non-steroidal, synthetic anti-inflammatory drugs. The commencement of trading of […]
The legal content provided by Fladgate LLP is for information purposes only and should not be relied on in any specific case without legal or other professional advice.
Copyright is owned by Fladgate LLP and all rights in such copyright are reserved. Material is not to be reproduced in whole or in part without prior written consent.
Fladgate LLP is a limited liability partnership, registered in England and Wales with registered number OC334334. It is authorised and regulated by the Solicitors Regulation Authority, number 484783. The term partner is used to refer to a member of Fladgate LLP. A list of members is available at the registered office shown above.